Showing results (1-10 of 842) with videos related to
Sort By:
Pageof 85
World Journal of Urology|May 26, 2001
Salvage chemotherapy in relapsed germ cell tumorsJ Beyer, O Rick, W Siegert, et al.Der Urologe. Ausg. A|March 4, 2009
[Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors]A Lorch, K Oechsle, C Bokemeyer, et al.Critical Reviews in Oncology/Hematology|September 10, 2003
Current aspects of high-dose chemotherapy in germ-cell tumorsO Rick, C Kollmannsberger, J Beyer, et al.World Journal of Urology|January 1, 1994
Treatment intensification in disseminated germ-cell tumorsJ Beyer, C Bokemeyer, H J Schmoll, et al.European Journal of Cancer (Oxford, England : 1990)|December 7, 2007
Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapyC Sammler, J Beyer, C Bokemeyer, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1994
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, H J Schmoll, F Natt, et al.World Journal of Urology|March 23, 2004
The role of high-dose chemotherapy in relapsed germ cell tumorsO Rick, C Kollmannsberger, J T Hartmann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.Oncology|April 29, 1998
Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumorsC BokemeyerPageof 85